June 10, 2024

U.S. Supplemental Health Market Size To Rake USD 59.42 Bn By 2032

The U.S. supplemental health market size was valued at USD 35.25 billion in 2022 and is projected to reach USD 59.42 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032, According to Precedence Research.

U.S. Supplemental Health Market Size 2023 To 2032

The global U.S. supplemental health market boons an in-depth synopsis of the competitive landscape of the market globally, thus helping establishments understand the primary threats and prospects that players/vendors in the market are dealt with. It also incorporates thorough business profiles of some of the prime vendors in the market.

Download The Sample Copy For Better Understanding@ https://www.precedenceresearch.com/sample/3063

U.S. Supplemental Health Market Report Scope

Report Coverage Details
Market Size in 2023 USD 36.8 Billion
Market Size by 2032 USD 59.42 Billion
Growth Rate from 2023 to 2032 CAGR of 5.5%
Base Year 2022
Forecast Period 2023 To 2032
Segments Covered By Product, By Distribution Channel, and By Demography

Also read: Industrial Seals Market Size To Rake USD 24.52 Bn By 2032

Benefits of this market

  • This study analyses the market size and share for U.S. supplemental health along with the present trends in the industry and forecasts for the future, showing investment opportunities for the future.
  • In order to compare the financial capabilities of the U.S. supplemental health market in the present, a quantitative analysis is done of the market from 2023 to 2032.
  • It is clear from this brilliant presentation of Porter’s Five Forces that buyers and suppliers have a lot of potential to gain from one another.
  • It is important to understand the most profitable trends in the U.S. supplemental health market in order to gain an advantage in the market.
  • A comprehensive analysis of the driving factors, limitations, and opportunities is provided in the report, along with an in-depth analysis of the effect they have on the market.
  • The report also includes the market share for U.S. supplemental health for several significant vendors as well as the latest developments in the market.

Leading players of the global U.S. supplemental health market are analysed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. Precedence Research provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global U.S. supplemental health market. Furthermore, the report offers two separate market forecasts – one for the production side and another for the consumption side of the global U.S. supplemental health market. It also provides useful recommendations for new as well as established players of the global U.S. supplemental health market.

The major players in the market

  • Aetna Inc.
  • Allianz S.E.
  • American International Group, Inc.
  • Anthem, Inc.
  • Assurant, Inc.
  • AXA Group
  • Cigna Corporation
  • Humana Inc.
  • MetLife, Inc.
  • Zurich Insurance Group AG

U.S. Supplemental Health Market Segmentations:

By Product

  • Critical Illness Insurance
  • Accident Insurance
  • Hospital Indemnity Insurance
  • Worksite Life
  • Dental

By Distribution Channel

  • Direct-to-Consumer (DTC)
  • Agents
  • Brokers
  • Others

By Demography

  • Individuals Aged 65 and Above
  • Individuals Aged Below 65 with an Eligible Disability

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Supplemental Health Market 

5.1. COVID-19 Landscape: U.S. Supplemental Health Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Supplemental Health Market, By Product

8.1. U.S. Supplemental Health Market, by Product, 2023-2032

8.1.1 Critical Illness Insurance

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Accident Insurance

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Hospital Indemnity Insurance

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Worksite Life

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Dental

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. U.S. Supplemental Health Market, By Distribution Channel

9.1. U.S. Supplemental Health Market, by Distribution Channel, 2023-2032

9.1.1. Direct-to-Consumer (DTC)

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Agents

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Brokers

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 10. U.S. Supplemental Health Market, By Demography 

10.1. U.S. Supplemental Health Market, by Demography, 2023-2032

10.1.1. Individuals Aged 65 and Above

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Individuals Aged Below 65 with an Eligible Disability

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. U.S. Supplemental Health Market, country Estimates and Trends Forecast

11.1. U.S.

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)

11.1.3. Market Revenue and Forecast, by Demography (2020-2032)

Chapter 12. Company Profiles

12.1. Aetna Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Allianz S.E.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. American International Group, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Anthem, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Assurant, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. AXA Group

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cigna Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Humana Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. MetLife, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Zurich Insurance Group AG

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Key inquiries addressed in the report:

  • Investigate the COVID 19 outbreak’s effects.
  • Our researchers give precise responses, pinpoint significant chances and fresh investments, and suggest excellent market strategy avenues.

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Leave a Reply

Your email address will not be published. Required fields are marked *